Biotechnology Johnson & Johnson Advances Its Two Bladder Cancer Studies, Releases Latest Data – Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology Brexit Impact On Drugs – Rising Shortages in UK Highlight Brexit Challenges – AstraZeneca (NASDAQ:AZN), Johnson & Johnson (NYSE:JNJ), GSK (NYSE:GSK) Read more
Biotechnology Johnson & Johnson Children’s Cough Syrup Contaminated In Some Batches – WHO Poised to Issue Global Alert – Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology FDA Mandates “Boxed Warning” For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies – Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Gilead Sciences (NASDAQ:GILD), Bristol-Myers Squibb (NYSE:BMY) Read more
Biotechnology Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future – Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology Johnson & Johnson Q1 Earnings Tops Wall Street Estimates On Strong Medical Devices Sales, Boosts Annual Outlook – Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology J&J Braces For Q1 Earnings With Bearish Charts And Patent Cliffs In Play – Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology Biedex Markets’s ‘Stock Whisper’ Index: 5 Stocks Investors Secretly Monitor But Don’t Talk About Yet Read more
Biotechnology Rare Disease-Focused Rallybio Inks Development Pact With Johnson & Johnson, Stock Shoots Higher – Rallybio (NASDAQ:RLYB), Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology Johnson & Johnson’s Carvykti Stands Ahead Of Bristol Myers’ Rival Blood Cancer Therapy With FDA Approval For Wider Population – Legend Biotech (NASDAQ:LEGN), Johnson & Johnson (NYSE:JNJ) Read more
